Neuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral Cardiomyopathy
- 1 October 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 48 (7) , 1438-1447
- https://doi.org/10.1016/j.jacc.2006.05.057
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Crystal Structure of a Truncated ErbB2 Ectodomain Reveals an Active Conformation, Poised to Interact with Other ErbB ReceptorsMolecular Cell, 2003
- ErbB2 Pathways in Heart and Neural DiseasesTrends in Cardiovascular Medicine, 2003
- Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heartThe Journal of Heart and Lung Transplantation, 2002
- ErbB2 is essential in the prevention of dilated cardiomyopathyNature Medicine, 2002
- Cardiac Dysfunction in the Trastuzumab Clinical ExperienceJournal of Clinical Oncology, 2002
- NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70S6K, and MEK-MAPK-RSKAmerican Journal of Physiology-Heart and Circulatory Physiology, 1999
- Neuregulin in Cardiac Hypertrophy in Rats With Aortic StenosisCirculation, 1999
- Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tailProceedings of the National Academy of Sciences, 1998
- Neuregulins Promote Survival and Growth of Cardiac MyocytesJournal of Biological Chemistry, 1998
- Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptorNature, 1995